The Latin America, Middle East and Africa Nootropics Market would witness market growth of 18.6% CAGR during the forecast period (2021-2027).
Modern medications like aniracetam, pramiracetam, piracetam, and cholinesterase inhibitors such as onepezil can be utilized as nootropic agents. Numerous companies are developing synthetic nootropics in form of pills, powders and drinks. Whereas, some major players are using Phyto-constituents found in many sections of plants, such as leaves, flowers, flower buds, stem bark, stem, seeds, and roots, in their products to make it more natural and appealing to the customers.
L-Theanine, an amino acid found in tea, is one of the nootropic agents that helps to increase focus and protect the brain against neurodegeneration. In addition, caffeine is another nootropic that helps to boost alertness and focus by stimulating the central nervous system. It also helps with alertness and reaction time.
The Abu Dhabi Health Authority (Haad) stated that the number of people who are in need of mental health care is underreported. In the recent years, the number of visits to the SKMC child psychiatry clinic has increased. Due to this high number of mental health issues, many experts suggest the consumption of some natural nootropics would be beneficial, which would augment its demand and growth across this region
The Brazil market dominated the LAMEA Nootropics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $539 million by 2027. The Argentina market is showcasing a CAGR of 19.2% during (2021 - 2027). Additionally, The UAE market would grow at a CAGR of 18.3% during (2021 - 2027).
Based on Distribution Channel, the market is segmented into Offline and Online. Based on Form, the market is segmented into Capsules/Tablets, Powder, Drinks, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Mental Mojo, LLC, Onnit Labs, Inc., Peak Nootropics (Advanced Nootropics), Reckitt Benckiser Group PLC, Mind Lab Pro (Opti-Nutra, ltd.), Zhou Nutrition LLC (Nutraceutical International Corporation)TruBrain, Wolfson Holdco Limited (NooCube), NEU MIND, LLC, and Kraken Koffee, LLC.
Scope of the Study
Market Segments covered in the Report:
By Distribution Channel
• Offline and
• Drinks, and
• Saudi Arabia
• South Africa
• Rest of LAMEA
• Mental Mojo, LLC
• Onnit Labs, Inc.
• Peak Nootropics (Advanced Nootropics)
• Reckitt Benckiser Group PLC
• Mind Lab Pro (Opti-Nutra, ltd.)
• Zhou Nutrition LLC (Nutraceutical International Corporation)TruBrain
• Wolfson Holdco Limited (NooCube)
• NEU MIND, LLC
• Kraken Koffee, LLC
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
The Global Nootropics Market size is expected to reach $24.6 billion by 2027, rising at a market growth of 14.7% CAGR during the forecast period. Nootropics refer to supplements, psychological enhancers, smart drugs, pharmaceuticals, or other substances which can help people to improve their cognitive function, especially executive...
The Asia Pacific Nootropics Market would witness market growth of 16.9% CAGR during the forecast period (2021-2027). Natural nootropics that have been commercialized react through various methods, thereby impacting different parameters. The release of dopamine, phosphatidylinositol turnover, choline absorption, function of the -amino-3-hydroxy-5-methyl-4-isoxazole...
The Latin America, Middle East and Africa Social and Emotional Learning (SEL) Market would witness market growth of 23.9% CAGR during the forecast period (2021-2027). With the constant technological advancements, various industries have witnessed a surge in growth including the education sector. Various education institutions and educators...
Summary Population Diagnostics Inc (Population Diagnostics) is a biotechnology company that carries out the research, development and discovery of platform technology for validation of causative genetic biomarkers. The company develops various therapeutic areas such as novel targeted drugs, drug rescue of Phase II & III failures,...
Summary BioCrea GmbH (BioCrea) is a healthcare company that offers drug discovery services. The company discovers and develops drugs to treat debilitating central nervous system diseases. It provides pipeline product PDE10, an inhibitor to treat Schizophrenia and Huntington’s disease. BioCrea offers discovery platforms such as...
Summary Advanced Technology Ventures (ATV) is a financial service provider that provides early stage investments in emerging growth companies and business development. The company operates on three core technology markets that include IT, healthcare and clean technology. Its healthcare services include next-generation biologics,...
Summary Zogenix Inc (Zogenix) is a pharmaceutical company that develops and commercializes injectable therapies and delivery systems for treating central nervous system disorders and pain. The company’s product portfolio includes Zohydro ER, Sumavel DosePro and undisclosed dosepro CNS product candidate. Its pipeline products include...
Summary LineaGen Inc (LineaGen), formerly GenData Research Corporation is a healthcare services provider that includes diagnostic service. The company provides diagnostic evaluation services for complex diseases. Its offers testing services such as FirstStepDx PLUS chromosomal micro array which detect deletions and duplication...
Summary Res-Care Inc (ResCare) is one of the largest home care companies and providers of services to people with disabilities. Its major services include daily personal care assistance; closed-door pharmacy related services; homemaking services; care management; skilled nursing / therapy; neuro therapy; live-in care and overnight...
Summary Naurex Inc (Naurex) is a clinical stage biopharmaceutical company that discovers and develops compounds that modulate the NMDA receptor. The company also develops new therapies for central nervous system diseases by modulating neuronal plasticity. It is developing an adjunctive therapy for depressive disorder in patients...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.